Related Experiment Video
Updated: Jul 11, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Mechanism of DNA-binding loss upon single-point mutation in p53
1Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan, ROC.
Abstract:
Over 50% of all human cancers involve p53 mutations,which occur mostly in the sequence-specific DNA-binding central domain (p53c), yielding little/non-detectable af?nity to the DNA consensus site. Despite our current understanding of protein-DNA recognition,the mechanism(s) underlying the loss in protein-DNA binding afnity/ specificity upon single-point mutation are not well understood. Our goal is to identify the common factors governing the DNA-binding loss of p53c upon substitution of Arg 273 to His or Cys,which are abundant in human tumours. By computing the free energies of wild-type and mutant p53c binding to DNA and decomposing them into contributions from individual residues, the DNA-binding loss upon charge/noncharge -conserving mutation of Arg 273 was attributed not only to the loss of DNA phosphate contacts, but also to longer-range structural changes caused by the loss of the Asp 281 salt-bridge. The results herein and in previous works suggest that Asp 281 plays a critical role in the sequence-specific DNA-binding function of p53c by (i)orienting Arg 273 and Arg 280 in an optimal position to interact with the phosphate and base groups of the consensus DNA, respectively, and (ii) helping to maintain the proper DNA-binding protein conformation.
Insights
Mutations in the p53 core domain (p53c) reduce DNA binding in over half of human cancers. Loss of the Asp 281 salt bridge, not just direct contacts, explains this reduced binding affinity for cancer-associated mutations.
Area of Science:
- Molecular Biology
- Biochemistry
- Structural Biology
Background:
- Over 50% of human cancers harbor mutations in the p53 tumor suppressor protein.
- Mutations frequently occur in the p53 core domain (p53c), impairing sequence-specific DNA binding.
- The precise mechanisms underlying loss of DNA binding affinity and specificity due to p53c mutations are not fully understood.
Purpose of the Study:
- To investigate the molecular factors responsible for the loss of DNA binding in p53c upon substitution of Arginine 273 (Arg 273) to Histidine (His) or Cysteine (Cys).
- To elucidate the role of specific residues and structural changes in mediating the functional consequences of common cancer-associated p53 mutations.
Main Methods:
- Computational analysis of free energies for wild-type and mutant p53c binding to DNA.
- Decomposition of binding free energies to identify contributions from individual amino acid residues.
- Analysis of structural changes and salt-bridge interactions.
Main Results:
- The loss of DNA binding affinity upon Arg 273 mutation (to His or Cys) is attributed to both direct loss of contacts with DNA phosphates and indirect, longer-range structural alterations.
- A critical salt bridge involving Aspartic acid 281 (Asp 281) was identified as a key factor in maintaining p53c DNA binding.
- Mutation of Arg 273 disrupts the Asp 281 salt bridge, leading to significant changes in protein-DNA interaction.
Conclusions:
- Asp 281 plays a crucial role in p53c sequence-specific DNA binding by correctly positioning key residues like Arg 273 and Arg 280.
- The integrity of the Asp 281 salt bridge is essential for maintaining the optimal protein conformation required for DNA binding.
- Understanding these mechanisms provides insights into p53 dysfunction in cancer and potential therapeutic strategies.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Abnormal Proliferation
Overview of DNA Repair
Chemically...
Spontaneous and Induced Mutations
Point and Frameshift Mutations

